VEGFA and type 2 diabetes mellitus: (Carlsson et al., 2018) AZD8601, a VEGF-A165 mRNA formulation, has been shown to stimulate the production of VEGF-A protein, enhancing basal skin blood flow in men with type 2 diabetes mellitus (T2DM).